Effect of Facility-Level Hemoglobin Concentration on Dialysis Patient Risk of Transfusion

Background Changes in anemia management practices due to concerns about erythropoiesis-stimulating agent safety and Medicare payment changes may increase patient risk of transfusion. We examined anemia management trends in hemodialysis patients and risk of red blood cell (RBC) transfusion according...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 2014-06, Vol.63 (6), p.997-1006
Hauptverfasser:	Collins, Allan J., MD, Monda, Keri L., PhD, Molony, Julia T., MS, Li, Suying, PhD, Gilbertson, David T., PhD, Bradbury, Brian D., DSc
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anemia Anemia - drug therapy Anemia - epidemiology Anemia - etiology Anemias. Hemoglobinopathies Biological and medical sciences Diseases of red blood cells end-stage renal disease Epoetin Alfa Erythrocyte Transfusion - statistics & numerical data Erythropoietin - therapeutic use Female Hematinics - therapeutic use Hematologic and hematopoietic diseases hemodialysis hemoglobin concentration Hemoglobins - analysis Humans Insurance Coverage Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Medical sciences Medicare Middle Aged Nephrology Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Recombinant Proteins - therapeutic use red blood cell transfusion Renal Dialysis Renal failure Retrospective Studies Risk Assessment United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!